StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) income statement

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.71−0.01 (-0.74%)

Close on Nov 19, 2026Market cap $8.31MP/E –Yield –

See a number that looks wrong?